Murthy Neil Chandra, Black Carla, Kahn Katherine E, Ding Helen, Ball Sarah, Fink Rebecca V, Devlin Rebecca, D'Angelo Denise, Fiebelkorn Amy Parker
Immunization Services Division (ISD), National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Epidemic Intelligence Service, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
Infect Dis (Auckl). 2020 Feb 10;13:1178633720904099. doi: 10.1177/1178633720904099. eCollection 2020.
Pregnant women are at increased risk of complications from influenza, and infants are at increased risk of pertussis. Maternal influenza and Tdap (tetanus, diphtheria, and acellular pertussis) vaccination can reduce risk of these infections and related complications. Our objective was to estimate vaccination coverage with influenza and Tdap vaccines during pregnancy among women with a recent live birth.
An opt-in Internet panel survey was conducted from March 28 to April 10, 2018 among pregnant and recently pregnant women. Respondents with a live birth from August 1, 2017 through the date in which the participant completed the survey were included in the analysis. Receipt of influenza vaccination since July 1, 2017 and Tdap vaccination during pregnancy were assessed by sociodemographic characteristics, receipt of a health care provider (HCP) recommendation and/or offer of vaccination, and vaccination-related knowledge, attitudes, and beliefs.
Less than a third (30.3%) of women with a live birth were unvaccinated during their pregnancy with both Tdap and influenza vaccines. Almost a third (32.8%) of the women reported being vaccinated with both vaccines. The majority (73.0%) of women reported receiving an HCP recommendation for both vaccines, and 54.2% of women were offered both vaccines by an HCP. Reasons for nonvaccination included negative attitudes toward influenza vaccine and lack of awareness about Tdap vaccination during pregnancy.
Maternal Tdap and influenza vaccinations can prevent morbidity and mortality among infants and their mothers, yet many pregnant women are unvaccinated with either Tdap or influenza vaccines. Clinic-based education, along with interventions, such as standing orders and provider reminders, are strategies to increase maternal vaccination.
孕妇患流感并发症的风险增加,婴儿患百日咳的风险增加。孕妇接种流感疫苗和破伤风类毒素、白喉、无细胞百日咳(Tdap)疫苗可降低这些感染及相关并发症的风险。我们的目的是估计近期有活产的孕妇在孕期接种流感疫苗和Tdap疫苗的覆盖率。
2018年3月28日至4月10日对孕妇和近期怀孕的妇女进行了一项自愿参与的互联网小组调查。分析纳入了2017年8月1日至参与者完成调查之日有活产的受访者。根据社会人口学特征、是否收到医疗保健提供者(HCP)的疫苗接种建议和/或接种提议以及与疫苗接种相关的知识、态度和信念,评估自2017年7月1日以来的流感疫苗接种情况以及孕期的Tdap疫苗接种情况。
近三分之一(30.3%)有活产的妇女在孕期未接种Tdap疫苗和流感疫苗。近三分之一(32.8%)的妇女报告接种了这两种疫苗。大多数(73.0%)妇女报告收到了HCP对这两种疫苗的接种建议,54.2%的妇女被HCP提供了这两种疫苗。未接种疫苗的原因包括对流感疫苗的负面态度以及对孕期Tdap疫苗接种缺乏认识。
孕妇接种Tdap疫苗和流感疫苗可预防婴儿及其母亲发病和死亡,但许多孕妇未接种Tdap疫苗或流感疫苗。基于诊所的教育以及诸如长期医嘱和提供者提醒等干预措施是提高孕妇疫苗接种率的策略。